{"id":353,"date":"2024-12-09T14:49:25","date_gmt":"2024-12-09T14:49:25","guid":{"rendered":"https:\/\/iefm.health\/public\/?page_id=353"},"modified":"2025-03-05T15:24:17","modified_gmt":"2025-03-05T15:24:17","slug":"webinar-2025-01","status":"publish","type":"page","link":"https:\/\/iefm.health\/public\/webinar\/webinar-2025-01\/","title":{"rendered":"Webinar &#8211; New Insights on Microclots"},"content":{"rendered":"\n<div class=\"wp-block-group alignfull has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-columns alignwide is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-top is-layout-flow wp-block-column-is-layout-flow\">\n<div style=\"height:5em\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h1 class=\"wp-block-heading\">New Insights on Microclots<\/h1>\n\n\n\n<h3 class=\"wp-block-heading\">A Potential Marker for Chronic Inflammation&nbsp;<\/h3>\n\n\n\n<h4 class=\"wp-block-heading\">Online Webinar (English)<\/h4>\n\n\n\n<p>21 January 2025 \u00b7 16.00 &#8211; 17.00 \u00b7 Online<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-top is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/iefm.health\/public\/wp-content\/uploads\/Events\/2025-Webinar\/January-Microclots\/TensorPix_small-1024x1024.jpg\" alt=\"\" class=\"wp-image-361\" style=\"aspect-ratio:4\/3;object-fit:cover\" srcset=\"https:\/\/iefm.health\/public\/wp-content\/uploads\/Events\/2025-Webinar\/January-Microclots\/TensorPix_small-1024x1024.jpg 1024w, https:\/\/iefm.health\/public\/wp-content\/uploads\/Events\/2025-Webinar\/January-Microclots\/TensorPix_small-300x300.jpg 300w, https:\/\/iefm.health\/public\/wp-content\/uploads\/Events\/2025-Webinar\/January-Microclots\/TensorPix_small-150x150.jpg 150w, https:\/\/iefm.health\/public\/wp-content\/uploads\/Events\/2025-Webinar\/January-Microclots\/TensorPix_small-768x768.jpg 768w, https:\/\/iefm.health\/public\/wp-content\/uploads\/Events\/2025-Webinar\/January-Microclots\/TensorPix_small-1536x1536.jpg 1536w, https:\/\/iefm.health\/public\/wp-content\/uploads\/Events\/2025-Webinar\/January-Microclots\/TensorPix_small-2048x2048.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h2 class=\"wp-block-heading has-text-align-center\">Details<\/h2>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h4 class=\"wp-block-heading has-text-align-left\">16.00 Welcome &amp; Introduction<\/h4>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h6 class=\"wp-block-heading has-text-align-left\">by Dr. Philip Mavberg<\/h6>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h4 class=\"wp-block-heading has-text-align-left\">16.10 Keynote &#8220;New Insights on Microclots&#8221;<\/h4>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>Amyloid fibrin microclots (AFMs) in human blood are increasingly recognized as significant indicators of health status, particularly in conditions such as post-acute COVID-19 syndrome (PACS), post-COVID-19 vaccination syndrome (PCVS), myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS), and in patients dealing with chronic inflammation. These microclots, which form due to vascular damage or exposure to inflammatory molecules, are commonly linked to various inflammatory diseases, with affected individuals showing increased numbers and sizes of AFMs. At INUS Laboratories, we have developed a novel method to detect and quantify AFMs using imaging flow cytometry. This protocol, optimized for platelet-poor plasma analysis, enables reliable detection of AFMs in blood samples processed within 24 hours of collection. To facilitate accurate analysis, a data framework was developed to define the size distribution of AFMs. Our method shows great potential for disease diagnosis and therapy monitoring. Despite logistical challenges, the ongoing development of this tool represents a significant advance in understanding and managing inflammation-related conditions.&nbsp;<\/p>\n\n\n\n<h6 class=\"wp-block-heading has-text-align-left\">by Dr. Yannick Kok<\/h6>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h4 class=\"wp-block-heading has-text-align-left\">16.40&nbsp;Q&amp;A Session<\/h4>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>You can enter your questions during the keynote presentation via the chat. We will try to answer as many questions as possible during the Q&amp;A session. Alternatively, you can contact us during the Q&amp;A so that we can unlock your microphone and you can ask your question directly.<\/p>\n\n\n\n<h6 class=\"wp-block-heading has-text-align-left\">moderated by Dr. Philip Mavberg<\/h6>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h4 class=\"wp-block-heading has-text-align-left\">16.55&nbsp;Wrap up &amp; Goodbye<\/h4>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New Insights on Microclots A Potential Marker for Chronic Inflammation&nbsp; Online Webinar (English) 21 January 2025 \u00b7 16.00 &#8211; 17.00 \u00b7 Online Details 16.00 Welcome &amp; Introduction by Dr. Philip Mavberg 16.10 Keynote &#8220;New Insights on Microclots&#8221; Amyloid fibrin microclots (AFMs) in human blood are increasingly recognized as significant indicators of health status, particularly in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":433,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-353","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/comments?post=353"}],"version-history":[{"count":10,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/353\/revisions"}],"predecessor-version":[{"id":390,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/353\/revisions\/390"}],"up":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/433"}],"wp:attachment":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/media?parent=353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}